Business Context and Reporting Period
This Form 8-K Current Report was filed by Bausch Health Companies Inc. on June 10, 2025. The filing reports on a significant capital market event involving Bausch + Lomb Corporation, a subsidiary of the registrant.
Key Financial Metrics and Capital Structure
The filing details a new debt issuance and credit facility refinancing rather than operational financial performance metrics such as revenue or profit.
- New Debt Issuance: Launch of an offering for €600 million aggregate principal amount of senior secured floating rate notes.
- New Credit Facilities:
- $2.2 billion new Term B loan facility.
- $800 million new revolving credit facility.
- Use of Proceeds: Repayment of outstanding borrowings under the existing revolving credit facility, full refinancing of outstanding Term A and Term B loans due in 2027, and payment of related fees and expenses. Remaining amounts will be used for general corporate purposes.
- Security: Notes are guaranteed by Bausch + Lomb and its subsidiaries and secured on a first priority basis by liens on assets securing the credit agreement and 8.375% senior secured notes due 2028.
Material Changes
The filing announces a material change in the capital structure of the Bausch + Lomb subsidiary through a partial refinancing of its credit agreement and the introduction of new senior secured notes. The filing text does not provide comparative financial data against prior periods as this is a transactional report.
Outlook, Risks, and Contingencies
Transaction Status: The transactions are subject to market and other conditions. There is no assurance that Bausch + Lomb will successfully complete the transactions on the described terms or at all.
Regulatory and Legal: The Notes are not registered under the U.S. Securities Act or Canadian securities laws and will be offered pursuant to exemptions. The filing explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy the Notes.
Independence of Transactions: The closing of the Notes offering is not contingent upon the closing of the new Term B Loan Facility or the new Revolving Credit Facility.
Investor Verification Checklist
- Verify the final closing status of the €600 million Notes offering and the $3.0 billion in new credit facilities.
- Confirm the specific interest rates and covenants associated with the new floating rate notes and Term B loan facility.
- Review the impact of the refinancing on the company's overall leverage ratios and debt maturity profile.
- Monitor for any updates regarding the repayment of the existing Term A and Term B loans due in 2027.